Online GLP-1 Sellers Often Bypass Meaningful Clinician Oversight
Direct-to-consumer telehealth platforms have changed how people access glucagon-like peptide-1 receptor agonists for managing obesity. A recent secret shopper…
Direct-to-consumer telehealth platforms have changed how people access glucagon-like peptide-1 receptor agonists for managing obesity. A recent secret shopper…
Recent polling data indicates that patient utilization of GLP-1 medications has reached its highest historical level. Eleven percent of…
Beverage companies are changing package sizes and messaging as GLP-1 receptor agonist medications alter consumer drinking habits. Industry analysts…
Nestle is changing some product formulations to meet the taste needs of patients using GLP-1 receptor agonists. Marketing chief…
A recent study shows that starting weight loss medications can lead to significant changes in a woman’s social and…
Glucagon-like peptide-1 receptor agonists have changed the way we treat obesity and type 2 diabetes. Medications like semaglutide and…
Medicare made a notable policy change on July 1 by extending limited coverage for weight management medications through the…
New research shows that women who use glucagon-like peptide-1 receptor agonists see measurable benefits in the job market. Harvard…
Organizations are still facing the significant financial challenges posed by GLP-1 receptor agonist medications. Recent survey data shows that…
Physicians are prescribing GLP-1 receptor agonists to children under twelve, despite the lack of specific federal approval. The Food…